Espeter, F.; Künne, D.; Garczarek, L.; Kuhlmann, H.; Skarabis, A.; Zivkovic, A.R.; Brenner, T.; Schmidt, K.
Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study. Diagnostics 2022, 12, 2150.
https://doi.org/10.3390/diagnostics12092150
AMA Style
Espeter F, Künne D, Garczarek L, Kuhlmann H, Skarabis A, Zivkovic AR, Brenner T, Schmidt K.
Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study. Diagnostics. 2022; 12(9):2150.
https://doi.org/10.3390/diagnostics12092150
Chicago/Turabian Style
Espeter, Florian, David Künne, Lena Garczarek, Henning Kuhlmann, Annabell Skarabis, Aleksandar R. Zivkovic, Thorsten Brenner, and Karsten Schmidt.
2022. "Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study" Diagnostics 12, no. 9: 2150.
https://doi.org/10.3390/diagnostics12092150
APA Style
Espeter, F., Künne, D., Garczarek, L., Kuhlmann, H., Skarabis, A., Zivkovic, A. R., Brenner, T., & Schmidt, K.
(2022). Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study. Diagnostics, 12(9), 2150.
https://doi.org/10.3390/diagnostics12092150